Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate
Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate
陽光生物製藥第一季度每股收益美元（2.00）未達到預期（1.04）美元，銷售額754萬美元超過700萬美元的預期
Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.04) by 92.31 percent. This is a 75 percent increase over losses of $(8.00) per share from the same period last year. The company reported quarterly sales of $7.54 million which beat the analyst consensus estimate of $7.00 million by 7.73 percent. This is a 54.08 percent increase over sales of $4.89 million the same period last year.
陽光生物製藥（納斯達克股票代碼：SBFM）公佈的季度虧損爲每股2.00美元，比分析師普遍預期的1.04美元（1.04美元）低92.31％。這比去年同期每股虧損8.00美元（8.00）增長了75％。該公司公佈的季度銷售額爲754萬美元，比分析師普遍預期的70萬美元高出7.73％。這比去年同期的489萬美元銷售額增長了54.08％。